New insights into how cancer evades the immune system

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach. They investigated how cancer affects the energy management of a patient’s T cells and showed for the first time that contact with chronic lymphocytic leukaemia (CLL) cells leads to a serious energy crisis in these cells. These findings are published today in Cellular & Molecular Immunology, building on a publication earlier this month in Blood Advances.

Read More

Tocolytic drugs that inhibit contractions after 30 weeks of pregnancy has no effect on a baby's health

The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health. “There was no benefit but also no harm done," says Amsterdam UMC PhD-student Larissa van der Windt. The results of the largest study concerning the effectiveness of tocolytic drugs on the health of babies, led by Amsterdam UMC, were published today in The Lancet.

Read More